Orexigen Therapeutics Inc (NASDAQ:OREX)

0.83
Delayed Data
As of Feb 16
 +0.0125 / +1.53%
Today’s Change
0.79
Today|||52-Week Range
4.88
-35.66%
Year-to-Date
No recent news for Orexigen Therapeutics Inc.

Today’s Trading

Previous close0.82
Today’s open0.84
Day’s range0.80 - 0.84
Volume254,195
Average volume (3 months)271,482
Market cap$15.7M
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+67.69%
Earnings growth (this year)-412.20%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+37.82%
P/E ratioNM
Price/Sales0.75
Price/Book0.21

Competitors

 Today’s
change
Today’s
% change
NTRPNeurotrope Inc+0.29+3.45%
CDMOPAvid Bioservices Inc+0.20+0.81%
PULMPulmatrix Inc-0.05-3.27%
PRPHProPhase Labs Inc+0.04+1.72%
Data as of 4:00pm ET, 02/16/2018

Financials

Next reporting dateMarch 28, 2018
EPS forecast (this quarter)-$2.06
Annual revenue (last year)$33.7M
Annual profit (last year)-$24.5M
Net profit margin-72.75%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
Chief Operating Officer &
Executive Vice President
Thomas R. Cannell
Corporate headquarters
La Jolla, California

Forecasts